The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night

Journal of Hypertension

Volumn 15, Issue 2, 1997, Pages 205-211

  Morgan, Trefor ^a   Anderson, Adrianne ^a   Jones, Elizabeth ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

24 hour blood pressure control; Ambulatory blood pressure monitoring; Angiotensin converting enzyme inhibitors; Chronotherapeutics; Hypertension; Perindopril

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CHRONOBIOLOGY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; MALE; NIGHT; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031044518     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715020-00012     Document Type: Article

References (27)

1. Australian Blood Pressure Study Management Committee: The Australian therapeutic trial in mild hypertension. Lancet 1980, i:1261-1267.
2. Medical Research Council Working Party in Mild to Moderate Hypertension: MRC trial of treatment of mild hypertension: principal results. BMJ 1985, 291:97-104.
3. Collins R, Pelo R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al.: Blood pressure, stroke and coronary heart disease: part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990, 335:827-838.
4. Morgan TO, Anderson A, Hopper J, Maskill G: Prognosis of male patients with treated hypertension followed over 15 years. Clin Exp Pharmacol P 1990, 17:211-213.
5. Kubacha RT, Juhl RP: Attitudes of patients with hypertension or arthritis towards the frequency of medication administration. Am J Hosp Pharm 1985, 42:2499-2501.
6. Blackwell B: Drug therapy: patient compliance. N Engl J Med 1973, 289:249-252.
7. Morgan TO, Nowson C, Murphy J, Snowden R: Compliance and the elderly hypertensive. Drugs 1986, 31 (suppl 4):174-182.
8. Todd PA, Fitton A: Perindopril: a review of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 1991, 42:90-114.
9. Todd PA, Faulds D: Felodipine: a review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders. Drugs 1992, 44:251-277.
10. Brogden RN, McTavish D: Nifedipine gastrointestinal therapeutic system (GITS): a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris. Drugs 1995, 50:495-512.
11. Murdoch D, Heel RC: Amlodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 1991, 41:478-505.
12. Plosker GL, Clissold SP: Controlled release metoprolol formulations: a review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease. Drugs 1992, 43:382-414.
13. Zannad F: Trandolapril: how does it differ from other angiotensin converting enzyme inhibitors. Drugs 1993, 46 (suppl 2):172-182.
14. Frishman WH: The safety and efficacy of quinapril in the treatment of mild to moderate hypertension. Clin Cardiol 1990, 13:19-25.
15. Myers A, Dewar HA: Circumstances attending 100 deaths from coronary artery disease with coroners' necropsies. Br Heart J 1975, 37:1133-1143.
16. Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Kiangos I, et al.: Circadian variation in the frequency of sudden cardiac death. Circulation 1987, 75:131-138.
17. Purcell H, Mulcahy D, Fox K: Circadian patterns of myocardial ischaemia and the effects of antianginal drugs. Chronobiol Int 1991, 8:309-320.
18. Anderson A, Morgan O, Morgan TO: Effectiveness of blood pressure control with once daily administration of enalapril and perindopril. Am J Hypertens 1994; 7:371-373.
19. Morgan T: Twenty four hour BP control - which is best, trough:peak ratios or ABPM? Br J Cardiol 1995, 2 (suppl 1):57-59.
20. Mengden T, Binswanger B, Spuhier T, Weisser B, Vetter W: The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens 1993, 11:1403-1411.
21. Palatini P, Racioppa A, Raule G, Zaninotto M, Penzo M, Pessina AC: Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther 1992, 52:378-383.
22. Witte K, Weisser K, Neubeck M, Mutschler E, Lehman K, Hopf R, et al.: Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther 1993, 54:177-186.
23. Plouin PF, Athene-Gelas F, Asdigrer JC, Fressinaud P, Dollin C, Cordelle B: Effets d'une prise unique de perindopril sur la pressure artérielle et le system renine-angiotensine, aldosterone chez l'hypertendu. Arch Mal Coeur 1987, 30:1078-1082.
24. Palatini P, Mos L, Motolese M, Morrnino P, DelTorre M, Varotto L, et al.: Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int J Clin Pharmacol Ther Toxicol 1993, 31:295-300.
25. Lemmer B: The chronopharmacology of cardiovascular medications. Ann Rev Chronopharmacol 1986, 2:199-228.
26. Brandenberger G, Follenius M, Goichot B, Saini J, Spiegel K, Ehrhart J, et al.: Twenty-four-hour profiles of plasma renin activity in relation to the sleep-wake cycle. J Hypertens 1994, 12:277-283.
27. Smith DHG, Neutel JM, Black HR, Schoenberger JA, Weber MA: Once-daily therapy with trandolapril in the treatment of hypertension. J Hum Hypertens 1996, 10:129-134.